+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 139 Pages
  • April 2023
  • GlobalData
  • Pfizer Inc.
  • ID: 1314910
Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pfizer Inc (Pfizer) discovers, develops, manufactures, and commercializes biopharmaceuticals. The company offers products to treat various conditions such as cardiovascular, metabolic and pain, women’s health, cancer, inflammation, immune disorders, and rare diseases. It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs) and contract manufacturing services. Pfizer sells its products through wholesalers, retailers, hospitals, individual provider offices, clinics, government agencies and pharmacies. It has major manufacturing facilities in India, China, Japan, Ireland, Italy, Belgium, Germany, Singapore, and the US. The company provides its products in North America, South America, Asia-Pacific, Australia, Europe, Africa, and the Middle East. Pfizer is headquartered in New York, the US.

Pfizer Inc Key Recent Developments

  • Apr 18, 2023: Coronavirus (COVID-19) Update: FDA authorizes changes to simplify use of Bivalent mRNA COVID-19 vaccines
  • Apr 13, 2023: Pfizer invites shareholders to attend virtual-only 2023 Annual Meeting of Shareholders on April 27
  • Apr 04, 2023: Arbutus Biopharma and Genevant Sciences file patent infringement lawsuit against Pfizer/BioNTech
  • Mar 14, 2023: Pfizer signs agreement to acquire Seagen for $43bn

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Pfizer Inc - Key Facts
  • Pfizer Inc - Key Employees
  • Pfizer Inc - Key Employee Biographies
  • Pfizer Inc - Major Products and Services
  • Pfizer Inc - History
  • Pfizer Inc - Company Statement
  • Pfizer Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Affiliate
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Pfizer Inc - Business Description
  • Product Category: Oncology
  • Overview
  • Performance
  • Product Category: Primary Care
  • Overview
  • Performance
  • Product Category: Specialty Care
  • Overview
  • Performance
  • Business Segment: Biopharma
  • Overview
  • Performance
  • Business Segment: PC1
  • Performance
  • Business Segment: Pfizer CentreOne (PC1)
  • Overview
  • Geographical Segment: Developed Europe
  • Target Markets
  • Performance
  • Geographical Segment: Developed Rest of World
  • Target Markets
  • Performance
  • Geographical Segment: Emerging Markets
  • Target Markets
  • Performance
  • Geographical Segment: United States
  • Performance
  • R&D Overview
  • Pfizer Inc - Corporate Strategy
  • Pfizer Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Pfizer Inc - Strengths
  • Pfizer Inc - Weaknesses
  • Pfizer Inc - Opportunities
  • Pfizer Inc - Threats
  • Pfizer Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Pfizer Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Apr 18, 2023: Coronavirus (COVID-19) Update: FDA authorizes changes to simplify use of Bivalent mRNA COVID-19 vaccines
  • Apr 13, 2023: Pfizer invites shareholders to attend virtual-only 2023 Annual Meeting of Shareholders on April 27
  • Apr 04, 2023: Arbutus Biopharma and Genevant Sciences file patent infringement lawsuit against Pfizer/BioNTech
  • Mar 14, 2023: Pfizer signs agreement to acquire Seagen for $43bn
  • Feb 21, 2023: NICE recommends 3 treatments for COVID-19 in final draft guidance
  • Feb 21, 2023: Vysioneer announces data sharing agreement with Pfizer to augment oncology clinical trials with Artificial Intelligence
  • Feb 03, 2023: Ada Health and Pfizer launch Covid-19 online platform
  • Jan 31, 2023: Pfizer reports record full-year 2022 results and provides full-year 2023 financial guidance
  • Jan 17, 2023: Pfizer expands ‘An Accord for a Healthier World’ product offering to include full portfolio for greater benefit to 1.2 billion people in 45 lower-income countries
  • Jan 06, 2023: Longevity Biotech Gero entered a research collaboration with Pfizer to discover potential targets for fibrotic diseases
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Pfizer Inc, Key Facts
  • Pfizer Inc, Key Employees
  • Pfizer Inc, Key Employee Biographies
  • Pfizer Inc, Major Products and Services
  • Pfizer Inc, History
  • Pfizer Inc, Subsidiaries
  • Pfizer Inc, Affiliate
  • Pfizer Inc, Joint Venture
  • Pfizer Inc, Key Competitors
  • Pfizer Inc, Ratios based on current share price
  • Pfizer Inc, Annual Ratios
  • Pfizer Inc, Interim Ratios
  • Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Pfizer Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Pfizer Inc, Performance Chart (2018 - 2022)
  • Pfizer Inc, Ratio Charts
  • Pfizer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Pfizer Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Takeda Pharmaceutical Co Ltd
  • Sanofi
  • Novartis AG
  • Eli Lilly and Co
  • AbbVie Inc
  • GSK plc
  • Amgen Inc
  • Merck & Co Inc
  • Dynavax Technologies Corp
  • AstraZeneca Plc
  • Generex Biotechnology Corp
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Bristol-Myers Squibb Co
  • AstraZeneca Plc
  • Takeda Pharmaceutical Co Ltd
  • Sanofi
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • GSK plc
  • Dynavax Technologies Corp
  • Amgen Inc
  • Generex Biotechnology Corp
  • Merck & Co Inc
  • Johnson & Johnson
  • Bristol-Myers Squibb Co
  • Eli Lilly and Co
  • AbbVie Inc